'Protease inhibitor' diaporamas de présentation

3.26k views • 304 slides

HIV-Associated Opportunistic Infections

HIV-Associated Opportunistic Infections. Jonathan Vilasier Iralu, MD, FACP Indian Health Service Chief Clinical Consultant for Infectious Diseases. Case.

1.54k views • 67 slides

Blood coagulation and fibrinolysis

Blood coagulation and fibrinolysis. March 2006. Haemostasis. adhesion shape change activation and secretion aggregation interaction with coagulation factors . Drug classes. 1. Anticoagulants 2. Antiplatelet drugs 3. Thrombolytic Agents . Anticoagulants. Heparin.

2.63k views • 63 slides

569 views • 46 slides

Unbound Docking of Rigid Molecules

641 views • 44 slides

Tipranavir NDA 21-814: Efficacy Evaluation

Tipranavir NDA 21-814: Efficacy Evaluation. Rafia Bhore, Ph.D. Statistician Reviewer Division of Antiviral Drug Products Food and Drug Administration. May 19, 2005 FDA Antiviral Drugs Advisory Committee Meeting. Outline of Efficacy Presentation. Study Design of Phase 3 Trials

548 views • 35 slides

HIV resistance: First Line Failures

HIV resistance: First Line Failures. Jesi Ramone, M.D. Clinical Assistant Professor STAR Health Center SUNY Downstate. Case Vignette.

461 views • 32 slides

Session 4

Session 4. October 6 th , 14:50 - 17:50. Written English formal, indirect audience can go back and re-read confusing sections. Spoken English informal, direct audience hears information only one time. Styles of English. Styles of English.

449 views • 31 slides

NY State AIDS Cancer Incidence (1981-1994)

348 views • 28 slides

NOVEL PARADIGMS FOR DRUG DISCOVERY SHOTGUN COMPUTATIONAL MULTITARGET SCREENING RAM SAMUDRALA

686 views • 25 slides

Metered dose inhaler containing aprotinin, a protease inhibitor, as a drug against Influenza

Metered dose inhaler containing aprotinin, a protease inhibitor, as a drug against Influenza. Oleg Zhirnov , N.Bokova , E. Isaeva , I. Vorobjeva , O. Saphonova , N. Malyshev. D.I.Ivanovsky Institute of Virology, Moscow, Russia Infectious clinics N1, Moscow, Russia. Influenza virus.

235 views • 23 slides

One-step affinity purification and processing of fusion proteins

One-step affinity purification and processing of fusion proteins. Philip Bryan. One-step purification:. affinity purification of fusion proteins, removal of the fusion domain isolation of the target protein. Target protein is fused onto an engineered pro-region of subtilisin.

361 views • 20 slides

Care of the Treatment- experienced Patient With HCV Infection Who Failed Prior Therapy

Care of the Treatment- experienced Patient With HCV Infection Who Failed Prior Therapy. Case 53-year-old Black Man. Case (cont). Case (cont). Case (cont). Second Treatment Regimen. Case (cont). Why Is Achieving SVR So Important?. Why Is Achieving SVR So Important?.

302 views • 19 slides

Differential Weighted Gene Coexpression Network Analysis Applied to Mouse Weight

Differential Weighted Gene Coexpression Network Analysis Applied to Mouse Weight. Tova Fuller Steve Horvath Department of Human Genetics University of California, Los Angeles ICSB, 10/5/07. Outline. Introduction: Single versus differential network analysis

303 views • 19 slides

2004-2005 Antiretrovirals Review

2004-2005 Antiretrovirals Review. 13 July 2014 7:54 AM. Abacavir. Antiretroviral Nucleoside reverse transcriptase inhibitor (NRTI). Delavirdine. Antiretroviral Non-nucleoside reverse transcriptase inhibitor (NNRTI). Didanosine. Antiretroviral

268 views • 13 slides

Richard S. L. Stein CS 379a February 21, 2006

BREED: Generating Novel Inhibitors through Hybridization of Known Ligands (A. C. Pierce, G. Rao, and G. W. Bemis). Richard S. L. Stein CS 379a February 21, 2006. Examining Protein-Ligand Interactions.

215 views • 11 slides

Predictor discovery in training set

MASS-Conductor. Prediction analysis of microarray (PAM). Cluster analysis. Platform Validation. Predictor discovery in training set. Predictor confirmation in testing set. Pattern analysis in all set. 2. 3. 4. 1. 5. Training set (10 AR, 10 STA, 6 BK). Testing set

180 views • 10 slides

Disparate Virologic Response to HAART between Ethnicities

809. Disparate Virologic Response to HAART between Ethnicities Amy Weintrob 1,2 , Greg Grandits 2,3 , Brian Agan 2,4 , Anuradha Ganesan 2,5 , Nancy Crum-Cianflone 2,6 , Susan Fraser 2,7 , Sugat Patel 2,8 , Glenn Wortmann 1,2 , Scott Wegner 2 , Vincent Marconi 2,4

93 views • 1 slides

Activation of Enzymes

Activation of Enzymes, HIV, and HSPs. NSF Grant # DUE0653234. David Coreas Molecular Biology dvdcoreas@yahoo.com Elena Betancourt Physiology and Neuroscience ebetancourt@ucsd.edu

164 views • 1 slides